-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ub4MZP76zt8qU8AZH10N5uIPGIFC433+nogQDHfGXl+j8XQlgjv94jAnqZVw/WL9 vAGXqrtx64WtkiJa/nhvDQ== 0001192482-09-000153.txt : 20090602 0001192482-09-000153.hdr.sgml : 20090602 20090602121259 ACCESSION NUMBER: 0001192482-09-000153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090529 FILED AS OF DATE: 20090602 DATE AS OF CHANGE: 20090602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Forte Phillip S CENTRAL INDEX KEY: 0001465315 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 09867416 MAIL ADDRESS: STREET 1: C/O IGI, INC. STREET 2: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGI INC CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: WHEAT RD AND LINCOCN AVE STREET 2: P O BOX 687 CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 6096971441 MAIL ADDRESS: STREET 1: WHEAT ROAD AND LINCOCN AVE STREET 2: P O BOX 687 CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2009-05-29 0000352998 IGI INC IG 0001465315 Forte Phillip S C/O IGI LABORATORIES, INC. 105 LINCOLN AVENUE BUENA NJ 08310 0 1 0 0 Controller Stock Option (Right to Buy) 1.01 2009-05-29 4 A 0 110000 0 A 2019-06-02 Common Stock 110000 110000 D The above equity grants to Mr. Forte will become fully vested over a period of three years as follows: (i) one-twelfth of the shares subject to the equity grants will vest on June 1, 2009; (ii) one-twelfth of the shares subject to the equity grants will vest on each of the following dates: (A) September 30, 2009, (B) December 31, 2009 and (C) March 31, 2010; (iii) one-third of the shares subject to the equity grants will vest on June 1, 2011; and (iv) one-third of the shares subject to the equity grants will vest on June 1, 2012. /s/ Phillip S. Forte 2009-06-02 -----END PRIVACY-ENHANCED MESSAGE-----